Curtis Layton in

Curtis Layton

Login to view DISC.
CEO, Co-Founder at Protillion Biosciences
📍 Carlsbad, California, United States

Curtis Layton is the CEO and Co-Founder of Protillion Biosciences, a company founded on technology he co-invented at Stanford. With a Ph. D. in Biochemistry from Duke University, he is an expert in therapeutic protein discovery, using proprietary AI and high-throughput technologies to engineer next-generation protein therapeutics.

His interests lie at the intersection of technology and biology, following advancements in adjacent fields like clinical genomics and personalized medicine. He actively engages with his professional network to discuss and promote innovation within the broader biotech landscape, showing a deep passion for the industrys future.

His companys technology can identify tens of thousands of pH-dependent antibody binders in a single run.

Read the full overview →
Experience
22 Years
Current Role
CEO, Co-Founder
Job Level
Leadership
Location
Carlsbad, California, United States
Personality Overview

How Curtis shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Curtis cares about

AI in Drug Discovery
He recently spoke about leveraging Big Data and Machine Learning for antibody discovery and actively promotes his company's on-chip/AI technology.
Protein Engineering
His entire professional focus is on a technology he co-invented for the discovery and optimization of therapeutic proteins and antibodies.
+4 more topics Login to view topics
Career

Work history

5-2019
CEO, Co-Founder
Protillion Biosciences
1-2016 - 5-2019
Research Scientist
Stanford University School of Medicine
2-2011 - 1-2016
Postdoctoral Research Fellow
Stanford University School of Medicine
9-2003 - 12-2010
Graduate Research Associate (Ph.D.)
Duke University Medical Center
In the press

Media appearances

Protillion Biosciences Raises $18 Million Series A Financing Led by Arch Venture Partners and Illumina Ventures. Featured in PR Newswire
See now
Company Spotlight – Protillion Biosciences. Featured in Illumina Ventures
+1 more appearances Login to view media
Education
2012 - 2016
Postdoctoral Fellowship
Stanford University School of Medicine
2011 - 2012
Postdoctoral Fellowship
Stanford University School of Medicine
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Curtis. Free, 10 seconds.